Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TAISHO PHARMACEUTICAL CO LTD
- Publication Date
- 2007-02-07
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a therapeutic agent for diseases believed to be associated with corticotropin releasing factor (CRF), such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's disease, Eating diseases, hypertension, gastrointestinal diseases, drug dependence, cerebral infarction, cerebral ischemia, cerebral edema, traumatic brain injury, inflammation, immune-related diseases, alopecia (alpecia), irritable bowel syndrome, sleep disorders, epilepsy , dermatitis, schizophrenia, pain, etc. Background technique
[0002] CRF is a hormone containing 41 amino acids (Science, 213, 1394-1397, 1981; and J. Neurosci., 7, 88-100, 1987), and it is believed that CRF plays a central role in the biological response against stress ( Cell. Mol. Neurobiol., 14, 579-588, 1994; Endocrinol., 132, 723-728, 1994; and Neuroendocrinol. 61, 445-452, 1995). For CRF, there are two pathways: the pathway by which CRF acts on the peripheral...